| Literature DB >> 32617309 |
Kai Wang1, Shi Zhao2,3, Huling Li4, Yateng Song4, Lei Wang1, Maggie H Wang2,3, Zhihang Peng5,6, Hui Li7, Daihai He8.
Abstract
BACKGROUND: Since the first appearance in Wuhan, China in December 2019, the novel coronavirus disease (COVID-19) has posed serious threats to the public health in many Chinese places and overseas. It is essential to quantify the transmissibility on real-time basis for designing public health responses.Entities:
Keywords: COVID-19; modelling; outbreak; reproduction number; serial interval
Year: 2020 PMID: 32617309 PMCID: PMC7327374 DOI: 10.21037/atm-20-1944
Source DB: PubMed Journal: Ann Transl Med ISSN: 2305-5839
Figure 1The geographic information map about cumulative number of confirmed COVID-19 cases as of February 16, 2020 in China.
Figure 2Epidemic curves for COVID-19 in (A) China, (B) Hubei province and (C) Wuhan and the real-time estimates of the time-varying reproduction numbers [R(t)]. Points show mean values; vertical lines show 95% confidence intervals. The red vertical dashed line indicates the traveling restriction in Wuhan on January 23, 2020. The orange vertical dashed line indicates the declaration of a PHEIC on January 30, 2020. The horizontal blue dashed line indicates the threshold value at 1.
Average daily reproduction numbers for cases of COVID-19 in different stages in China, Hubei and Wuhan with SI at 7.5 days
| Period | China | Hubei | Wuhan | |||||
|---|---|---|---|---|---|---|---|---|
|
| 95% CI |
| 95% CI |
| 95% CI | |||
| Stage I | 8.29 | (7.74, 8.86) | 7.10 | (6.54, 7.66) | 4.85 | (4.37, 5.32) | ||
| Stage II | 3.26 | (3.13, 3.36) | 3.76 | (3.57, 3.96) | 3.71 | (3.39, 4.03) | ||
| Stage III | 0.97 | (0.89, 1.07) | 1.12 | (1.02, 1.22) | 1.44 | (1.31, 1.59) | ||
The effect of under-report rate in the early outbreak on the average daily reproduction number with different stages in China, Hubei and Wuhan with SI at 7.5 days
| Under-report rate | Period | China | Hubei | Wuhan | |||||
|---|---|---|---|---|---|---|---|---|---|
|
| 95% CI |
| 95% CI |
| 95% CI | ||||
| 20% | Stage I | 7.68 | (7.21, 8.16) | 6.39 | (5.92, 6.87) | 4.28 | (3.89, 4.69) | ||
| Stage II | 2.95 | (2.84, 3.05) | 3.44 | (3.27, 3.60) | 3.47 | (3.19, 3.75) | |||
| Stage III | 0.97 | (0.89, 1.06) | 1.11 | (1.02, 1.22) | 1.44 | (1.31, 1.58) | |||
| 30% | Stage I | 7.36 | (6.92, 7.80) | 6.02 | (5.59, 6.45) | 3.99 | (3.64, 4.35) | ||
| Stage II | 2.77 | (2.68, 2.87) | 3.25 | (3.10, 3.40) | 3.33 | (3.07, 3.60) | |||
| Stage III | 0.96 | (0.88, 1.06) | 1.11 | (1.02, 1.22) | 1.44 | (1.31, 1.58) | |||
| 40% | Stage I | 7.03 | (6.64, 7.43) | 5.64 | (5.26, 6.03) | 3.69 | (3.37, 4.01) | ||
| Stage II | 2.59 | (2.50, 2.68) | 3.05 | (2.91, 3.19) | 3.18 | (2.94, 3.43) | |||
| Stage III | 0.96 | (0.88, 1.05) | 1.11 | (1.01, 1.21) | 1.44 | (1.30, 1.58) | |||
Average daily reproduction numbers for cases of COVID-19 in different stages in China, Hubei and Wuhan
| Period | China | Hubei | Wuhan | |||||
|---|---|---|---|---|---|---|---|---|
|
| 95% CI |
| 95% CI |
| 95% CI | |||
| Stage I | 4.95 | (4.26, 5.67) | 4.29 | (3.66, 4.93) | 3.88 | (3.30, 4.49) | ||
| Stage II | 2.61 | (2.47, 2.75) | 2.76 | (2.54, 2.95) | 2.71 | (2.43, 3.01) | ||
| Stage III | 0.98 | (0.96, 1.03) | 1.14 | (1.10, 1.19) | 1.41 | (1.35, 1.48) | ||
The effect of under-report rate in the early outbreak on the average daily reproduction number with different stages in China, Hubei and Wuhan
| Under-report rate | Period | China | Hubei | Wuhan | |||||
|---|---|---|---|---|---|---|---|---|---|
|
| 95% CI |
| 95% CI |
| 95% CI | ||||
| 20% | Stage I | 3.40 | (3.09, 3.70) | 2.83 | (2.52, 3.14) | 2.34 | (2.06, 2.63) | ||
| Stage II | 2.10 | (2.01, 2.19) | 2.33 | (2.20, 2.47) | 2.45 | (2.21, 2.69) | |||
| Stage III | 1.02 | (0.98, 1.06) | 1.11 | (1.07, 1.16) | 1.31 | (1.24, 1.38) | |||
| 30% | Stage I | 3.35 | (3.06, 3.63) | 2.77 | (2.48, 3.06) | 2.24 | (1.98, 2.50) | ||
| Stage II | 2.02 | (1.94, 2.10) | 2.24 | (2.11, 2.36) | 2.32 | (2.11, 2.54) | |||
| Stage III | 1.02 | (0.97, 1.06) | 1.11 | (1.06, 1.16) | 1.31 | (1.24, 1.38) | |||
| 40% | Stage I | 3.30 | (3.04, 3.57) | 2.70 | (2.45, 2.96) | 2.14 | (1.91, 2.38) | ||
| Stage II | 1.93 | (1.85, 2.00) | 2.13 | (2.02, 2.25) | 2.19 | (1.99, 2.40) | |||
| Stage III | 1.01 | (0.97, 1.06) | 1.11 | (1.06, 1.16) | 1.31 | (1.24, 1.38) | |||